High levels of pro‐inflammatory cytokines, including tumor necrosis factor, interleukin (IL)‐1, and IL‐6, are related with the primary noninfectious systemic inflammation and hypercoagulable condition that characterize parenteral symptoms of IBD.24, 25. This evidence concerns the gene IL6 and inflammatory response.